A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...
MENOPAUSE and prostate patients will be some of the first to use the new NHS “online hospital” next year. The completely ...
Taiwan recorded 138,051 new cancer cases in 2023, 7,758 more than in 2022, the Health Promotion Administration (HPA) reported ...
Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...
Gene Hackman, star of “'Hoosiers,” died at his Santa Fe home in February. The actor was 95 and beloved by Hoosiers for his ...
Over the past six years, patients and their surviving relatives have filed at least eight malpractice suits over allegedly ...
The company highlighted multiple myeloma and CAR T therapies as growth drivers and announced two new US manufacturing ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback